Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Romania
Management Report
Published: January 2010
Pages: 34
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Romania is located in South-Eastern Europe, bordering Hungary, Ukraine, Moldova, Bulgaria and Serbia. In 2010 the population is estimated at 21.4 million, making it one of the largest countries in the region. Romania became an EU member state in 2007.
Around 89% of the pharmaceutical market is supplied by imports. Germany, France and Hungary were the leading suppliers in 2007, accounting for over 40% of the total. Imports grew by 25.8% in 2007, reaching US$1.9 billion.
The quality of drug production has risen since the enforcement of GMP on 1st January 2004. However, the number of local drug producers fell from 71 to 31 as a result. Romania became a full member of the European Pharmacopoeia Convention in September 2003, and all medicinal products marketed in the country must be measured against the organisation’s standards.
A number of acquisitions have taken place in the market, including that of Sicomed in September 2005, whereby Zentiva of the Czech Republic obtained a 51% stake in the company, later increasing its share to 74.9%. In March 2006, Actavis, the Icelandic generics manufacturer, acquired Sindan, a Romanian generics company specialising in oncology products, for US$17 million. In the same month, Ranbaxy Laboratories Limited, India’s largest generics manufacturer, acquired Terapia S.A. for US$324 million, purchasing 96.7% of the company’s shares.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel
Around 89% of the pharmaceutical market is supplied by imports. Germany, France and Hungary were the leading suppliers in 2007, accounting for over 40% of the total. Imports grew by 25.8% in 2007, reaching US$1.9 billion.
The quality of drug production has risen since the enforcement of GMP on 1st January 2004. However, the number of local drug producers fell from 71 to 31 as a result. Romania became a full member of the European Pharmacopoeia Convention in September 2003, and all medicinal products marketed in the country must be measured against the organisation’s standards.
A number of acquisitions have taken place in the market, including that of Sicomed in September 2005, whereby Zentiva of the Czech Republic obtained a 51% stake in the company, later increasing its share to 74.9%. In March 2006, Actavis, the Icelandic generics manufacturer, acquired Sindan, a Romanian generics company specialising in oncology products, for US$17 million. In the same month, Ranbaxy Laboratories Limited, India’s largest generics manufacturer, acquired Terapia S.A. for US$324 million, purchasing 96.7% of the company’s shares.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel